Bank of New York Mellon’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $247K | Sell |
|
|||||
|
2025
Q2 | $260K | Buy |
|
|||||
|
2025
Q1 | $276K | Buy |
|
|||||
|
2024
Q4 | $348K | Buy |
|
|||||
|
2024
Q3 | $243K | Sell |
|
|||||
|
2024
Q2 | $538K | Buy |
|
|||||
|
2024
Q1 | $206K | Sell |
|
|||||
|
2023
Q4 | $230K | Sell |
|
|||||
|
2023
Q3 | $626K | Buy |
|
|||||
|
2023
Q2 | $649K | Buy |
|
|||||
|
2023
Q1 | $405K | Sell |
|
|||||
|
2022
Q4 | $408K | Buy |
|
|||||
|
2022
Q3 | $121K | Buy |
|
|||||
|
2022
Q2 | $49K | Sell |
|
|||||
|
2022
Q1 | $354K | Sell |
|
|||||
|
2021
Q4 | $961K | Buy |
|
|||||
|
2021
Q3 | $1.2M | Buy |
|
|||||
|
2021
Q2 | $1.07M | Buy |
|
|||||
|
2021
Q1 | $891K | Sell |
|
|||||
|
2020
Q4 | $665K | Buy |
|
|||||
|
2020
Q3 | $509K | Buy |
|
|||||
|
2020
Q2 | $525K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $204K | Buy |
|
|||||
|
2018
Q4 | $138K | Buy |
|
|||||
|
2018
Q3 | $804K | Buy |
|
|||||
|
2018
Q2 | $626K | Buy |
|
|||||
|
2018
Q1 | $379K | Sell |
|
|||||
|
2017
Q4 | $365K | Sell |
|
|||||
|
2017
Q3 | $748K | Buy |
|
|||||
|
2017
Q2 | $644K | Buy |
|
|||||
|
2017
Q1 | $211K | Buy |
|